温度响应型水凝胶注射切口用于腹腔镜腹部手术后镇痛:单盲随机关键临床试验
结果显示PF-72组术后72小时内伤口疼痛NRS曲线下面积显著低于对照组,且未观察到与PF-72相关的不良事件。
要点
- PF-72混合0.75%罗哌卡因切口注射可降低腹腔镜术后72小时伤口疼痛。
- 两组在普通病房补救镇痛药使用频率相似。
- 研究样本量不足以评估安全性,但未观察到PF-72相关不良事件。
核心结论
- PF-72混合0.75%罗哌卡因可减少腹腔镜手术患者术后72小时内的疼痛。
主要发现
- 术后72小时内伤口疼痛NRS曲线下面积对照组为188.7 ± 46.1 h,PF-72组为135.3 ± 49.9 h(P < 0.001)。
- 普通病房补救镇痛药使用频率两组相似。
- 未观察到与PF-72相关的不良事件。
关键数值与推荐
- PF-72在低温(2-8 °C)可溶,高温(> 30 °C)转化为凝胶。
- 术后疼痛采用NRS(0=无痛,10=最痛)在术后3、6、24、48、72小时评估伤口疼痛。
- 在关闭手术切口前,将0.75%罗哌卡因或PF-72混合0.75%罗哌卡因注射至所有切口的皮下脂肪和肌肉。
临床怎么用
- 对于腹腔镜胃或结直肠手术患者,可考虑在切口关闭前注射PF-72混合0.75%罗哌卡因以延长术后镇痛时间。
- 需注意本研究样本量不足以充分评估安全性,临床使用时仍需监测不良事件。
局限性
- 研究人群不够大,不足以评估安全性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: A temperature-responsive hydrogel (PF-72; TGel Bio, Inc., Ltd, Seoul, Korea), developed as a sustained drug delivery device, can be mixed with ropivacaine to reduce pain in the incision area. The hydrogel is soluble at low temperatures (2-8 °C) and is converted into a gel at high temperatures (> 30 °C). We aimed to evaluate whether the administration of ropivacaine using PF-72 at incision sites reduces pain until 72 h postoperatively in patients undergoing laparoscopic stomach or colorectal surgery. METHODS: Patients were randomly assigned to the control group (0.75% ropivacaine) or PF-72 group (PF-72 mixed with 0.75% ropivacaine). Before surgical incision closure, 0.75% ropivacaine or PF-72 mixed with 0.75% ropivacaine was injected into the subcutaneous fat and muscle of all incisions. Postoperative pain was evaluated by the Numerical Rating Scale (NRS, 0 = no pain, 10 = most severe pain) for wound pain at 3, 6, 24, 48, and 72 h after the end of surgery. RESULTS: Ninety-nine patients (control, n = 51; PF-72, n = 48) were included in the analysis. The areas under the curve of NRS for wound pain until 72 h in the control group and the PF-72 group were 188.7 ± 46.1 and 135.3 ± 49.9 h, respectively (P < 0.001). The frequency of the administration of rescue analgesics in the general ward was similar between the two groups. CONCLUSION: PF-72 mixed with 0.75% ropivacaine reduced postoperative pain until 72 h in patients undergoing laparoscopic surgery. Although the study population was not large enough for safety evaluation, no adverse events associated with PF-72 were observed.
引用
- Choi BM, Hwang CS, Yoon YS, et al. Novel temperature-responsive hydrogel injected to the incision site for postoperative pain relief in laparoscopic abdominal surgery: a single-blind, randomized, pivotal clinical trial. Surg Endosc. 2022. PMID: 35556170. doi:10.1007/s00464-022-09252-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。